Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
R
302550
vs
K
KOSPI 200
Over the past 12 months, Remed Co Ltd has underperformed KOSPI 200, delivering a return of -29% compared to KOSPI 200's +65% growth.
Stocks Performance
302550 vs KOSPI 200
Performance Gap
302550 vs KOSPI 200
Performance By Year
302550 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Remed Co Ltd
Glance View
Remed Co Ltd makes respiratory care and sleep-apnea devices used in hospitals and at home. Its product line centers on noninvasive breathing support equipment such as CPAP and related devices, along with accessories and consumables that go with them. The company sells to hospitals, clinics, distributors, and home-care customers who need long-term treatment for breathing and sleep disorders. The business makes money mainly by selling these devices and the parts that need to be replaced or replenished over time. In this kind of market, the first device sale often leads to repeat demand for masks, tubing, filters, and other accessories, which helps create a steady follow-on revenue stream. Remed sits in a specialized niche between medical-device makers and the doctors, hospitals, and patients who use respiratory therapy every day. What makes Remed’s role distinct is that it focuses on a very specific medical need: helping people breathe more easily and sleep more safely without invasive treatment. That gives the company a product set tied to chronic care rather than one-time procedures. Its business depends on reliable devices, clinical trust, and ongoing use of consumables, which are central features of the respiratory-care industry.